Oleoylethanolamide Supplementation Reduces Inflammation and Oxidative Stress in Obese People: A Clinical Trial

Laleh Payahoo ¹ , Yaser Kahjebishak ² , Mohammad Asghari Jafarabadi ³ , Alireza Ostadrahimi ⁴ *

Cited by CrossRef: 31

1- Otagiri S, Ohnishi S, Ohara M, Fu Q, Yamamoto K, Yamamoto K, Katsurada T, Sakamoto N. Oleoylethanolamide Ameliorates Dextran Sulfate Sodium-Induced Colitis in Rats. Front Pharmacol. 2020;11 [Crossref]

2- Razmi H, Tarighat-Esfanjani A, Payahoo L, Mobasseri M, Amirpour M, Mirzaei E, Ghoreishi Z. Relationship between the levels of serum fibroblast growth factor 19 and metabolic factors in obese and normal weight subjects with and without type 2 diabetes mellitus: a case-control study. 2021;42(1):11 [Crossref]

3- Forner-Piquer I, Beato S, Piscitelli F, Santangeli S, Di Marzo V, Habibi H, Maradonna F, Carnevali O. Effects of BPA on zebrafish gonads: Focus on the endocannabinoid system. Environmental Pollution. 2020;264:114710 [Crossref]

4- Pouryousefi E, Javadi M, Hashemipour S, Nooshabadi M, Haghighian H. Improved glycemic status, insulin resistance and inflammation after receiving oral oleoylethanolamide supplement in people with prediabetes: a randomized controlled trial. Diabetol Metab Syndr. 2022;14(1) [Crossref]

5- Laleh P, Yaser K, Alireza O. Oleoylethanolamide: A novel pharmaceutical agent in the management of obesity‐an updated review. Journal Cellular Physiology. 2019;234(6):7893 [Crossref]

6- Tutunchi H, Ostadrahimi A, Saghafi‐Asl M, Roshanravan N, Shakeri‐Bavil A, Asghari‐Jafarabadi M, Farrin N, Mobasseri M. Expression of NF‐κB, IL‐6, and IL‐10 genes, body composition, and hepatic fibrosis in obese patients with NAFLD—Combined effects of oleoylethanolamide supplementation and calorie restriction: A triple‐blind randomized controlled clinical trial. Journal Cellular Physiology. 2021;236(1):417 [Crossref]

7- Akbari N, Ostadrahimi A, Tutunchi H, Pourmoradian S, Farrin N, najafipour F, Soleimanzadeh H, Kafil B, Mobasseri M. Possible therapeutic effects of boron citrate and oleoylethanolamide supplementation in patients with COVID-19: A pilot randomized, double-blind, clinical trial. Journal of Trace Elements in Medicine and Biology. 2022;71:126945 [Crossref]

8- Armeli F, Bonucci A, Maggi E, Pinto A, Businaro R. Mediterranean Diet and Neurodegenerative Diseases: The Neglected Role of Nutrition in the Modulation of the Endocannabinoid System. Biomolecules. 2021;11(6):790 [Crossref]

9- Ghaffari S, Roshanravan N, Tutunchi H, Ostadrahimi A, Pouraghaei M, Kafil B. Oleoylethanolamide, A Bioactive Lipid Amide, as A Promising Treatment Strategy for Coronavirus/COVID-19. Archives of Medical Research. 2020;51(5):464 [Crossref]

10- Azbukina N, Lopachev A, Chistyakov D, Goriainov S, Astakhova A, Poleshuk V, Kazanskaya R, Fedorova T, Sergeeva M. Oxylipin Profiles in Plasma of Patients with Wilson’s Disease. Metabolites. 2020;10(6):222 [Crossref]

11- Klawitter J, Sempio C, Jackson M, Smith P, Hopp K, Chonchol M, Gitomer B, Christians U, Klawitter J. Endocannabinoid System in Polycystic Kidney Disease. Am J Nephrol. 2022;53(4):264 [Crossref]

12- Jung K, Lin L, Piomelli D. The endocannabinoid system in the adipose organ. Rev Endocr Metab Disord. 2022;23(1):51 [Crossref]

13- Pai A, Wenziger C, Streja E, Argueta D, DiPatrizio N, Rhee C, Vaziri N, Kalantar-Zadeh K, Piomelli D, Moradi H. Impact of Circulating N-Acylethanolamine Levels with Clinical and Laboratory End Points in Hemodialysis Patients. Am J Nephrol. 2021;52(1):59 [Crossref]

14- Quentin A, Dieter F, Reutzel M, Eckert G. Oleoylethanolamide improves energy disposal in a cellular model of Alzheimer’s disease. Journal of Mitochondria, Plastids and Endosymbiosis. 2024;2(1) [Crossref]

15- Liu Y, Liu Q, Krivoruchko A, Khoomrung S, Nielsen J. Engineering yeast phospholipid metabolism for de novo oleoylethanolamide production. Nat Chem Biol. 2020;16(2):197 [Crossref]

16- Sgroi S, Romeo E, Fruscia P, Porceddu P, Russo D, Realini N, Albanesi E, Bandiera T, Bertozzi F, Reggiani A. Inhibition of N-acylethanolamine-hydrolyzing acid amidase reduces T cell infiltration in a mouse model of multiple sclerosis. Pharmacological Research. 2021;172:105816 [Crossref]

17- Dopkins N, Neameh W, Hall A, Lai Y, Rutkovsky A, Gandy A, Lu K, Nagarkatti P, Nagarkatti M. Effects of Acute 2,3,7,8-Tetrachlorodibenzo-p-Dioxin Exposure on the Circulating and Cecal Metabolome Profile. IJMS. 2021;22(21):11801 [Crossref]

18- Kazemi M, Lalooha F, Nooshabadi M, Haghighian H. Decreased dysmenorrhea pain in girls by reducing oxidative stress and inflammatory biomarkers following supplementation with oleoylethanolamide: A randomized controlled trial. J of Obstet and Gynaecol. 2022;48(5):1212 [Crossref]

19- Payahoo L, Khajebishak Y, Alivand M, Soleimanzade H, Alipour S, Barzegari A, Ostadrahimi A. Investigation the effect of oleoylethanolamide supplementation on the abundance of Akkermansia muciniphila bacterium and the dietary intakes in people with obesity: A randomized clinical trial. Appetite. 2019;141:104301 [Crossref]

20- Fernández-Quintela A, Milton-Laskibar I, Trepiana J, Gómez-Zorita S, Kajarabille N, Léniz A, González M, Portillo M. Key Aspects in Nutritional Management of COVID-19 Patients. JCM. 2020;9(8):2589 [Crossref]

21- Rhodes C, Zhu C, Agus J, Tang X, Li Q, Engebrecht J, Zivkovic A. Human fasting modulates macrophage function and upregulates multiple bioactive metabolites that extend lifespan in Caenorhabditis elegans: a pilot clinical study. The American Journal of Clinical Nutrition. 2023;117(2):286 [Crossref]

22- Santa-María C, López-Enríquez S, Montserrat-de la Paz S, Geniz I, Reyes-Quiroz M, Moreno M, Palomares F, Sobrino F, Alba G. Update on Anti-Inflammatory Molecular Mechanisms Induced by Oleic Acid. Nutrients. 2023;15(1):224 [Crossref]

23- Hu J, Zhu Z, Ying H, Yao J, Ma H, Li L, Zhao Y. Oleoylethanolamide Protects Against Acute Liver Injury by Regulating Nrf-2/HO-1 and NLRP3 Pathways in Mice. Front Pharmacol. 2021;11 [Crossref]

24- Tutunchi H, Zolrahim F, Nikbaf-Shandiz M, Naeini F, Ostadrahimi A, Naghshi S, Salek R, Najafipour F. Effects of oleoylethanolamide supplementation on inflammatory biomarkers, oxidative stress and antioxidant parameters of obese patients with NAFLD on a calorie-restricted diet: A randomized controlled trial. Front Pharmacol. 2023;14 [Crossref]

25- Mane M, Patil R, Magdum A, Kakade S, Patil D, Nimbalkar M. Chemo-profiling by UPLC-QTOF MS analysis and in vitro assessment of Anti-inflammatory activity of Field Milkwort (Polygala arvensis Willd.). South African Journal of Botany. 2022;149:49 [Crossref]

26- Akdad M, Ameziane R, Khallouki F, Bakri Y, Eddouks M. Antidiabetic Phytocompounds Acting as Glucose Transport Stimulators. EMIDDT. 2023;23(2):147 [Crossref]

27- Tutunchi H, Ostadrahimi A, Saghafi‐Asl M, Maleki V. The effects of oleoylethanolamide, an endogenous PPAR‐α agonist, on risk factors for NAFLD: A systematic review. Obesity Reviews. 2019;20(7):1057 [Crossref]

28- Dastah S, Tofighi A, Tolouei Azar J, Alivand M. Aerobic exercise leads to upregulation of Mir-126 and angiogenic signaling in the heart tissue of diabetic rats. Gene Reports. 2020;21:100914 [Crossref]

29- Liu F, Smith A, Wang T, Pham Q, Cheung L, Yang H, Li R. Biological pathways via which the anthocyanin malvidin alleviated the murine colitis induced by Citrobacter rodentium. Food Funct. 2023;14(2):1048 [Crossref]

30- Pacher P, Kogan N, Mechoulam R. Beyond THC and Endocannabinoids. Annu Rev Pharmacol Toxicol. 2020;60(1):637 [Crossref]

31- Sabahi M, Ahmadi S, Kazemi A, Mehrpooya M, Khazaei M, Ranjbar A, Mowla A, Giudetti A. The Effect of Oleoylethanolamide (OEA) Add-On Treatment on Inflammatory, Oxidative Stress, Lipid, and Biochemical Parameters in the Acute Ischemic Stroke Patients: Randomized Double-Blind Placebo-Controlled Study. Oxidative Medicine and Cellular Longevity. 2022;2022:1 [Crossref]